The Georgian Health Digest: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Georgian Health Digest.

Press releases published on September 17, 2026

3 hours ago

BioTech Social Announces Advisory Board to Advance Financial Innovation for Life Science Companies

Indeterminate GlobeNewswire

4 hours ago

Treace Announces Results of Three Clinical Studies Including the Milestone 5-Year ALIGN3D® Study Demonstrating Sustained, Positive Outcomes of the Lapiplasty® Procedure

Indeterminate GlobeNewswire

4 hours ago

Onco360® Has Been Selected as a National Pharmacy Partner for ETCAMAH™ (camizestrant)

Indeterminate GlobeNewswire

4 hours ago

NOMAD POWER SOLUTIONS FILES EXPANDED BUSINESS AND FINANCIAL DISCLOSURE FOLLOWING COMPLETION OF MERGER

Indeterminate GlobeNewswire

5 hours ago

Phase 3 Pediatric EMPAVELI Data Published in Clinical Journal of the American Society of Nephrology Show Reduction in Proteinuria and Stabilized Kidney Function in Adolescents with C3G or Primary IC-MPGN

Indeterminate GlobeNewswire

5 hours ago

Beta Bionics Announces Closing of $172.5 Million Public Offering of Common Stock

Indeterminate GlobeNewswire

5 hours ago

Dyne Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

5 hours ago

Vireo Growth Inc. Announces Issuance of Shares in Connection with Altmore Settlement

Indeterminate GlobeNewswire

5 hours ago

argenx announces results of Extraordinary General Meeting of Shareholders and appointment of Thomas M. Brakel and Khurem Farooq as Non-Executive Directors

Indeterminate GlobeNewswire

5 hours ago

Xenon Announces Azetukalner NDA Submission to FDA for Focal Seizures and Provides Update on Psychiatry Clinical Program

Indeterminate GlobeNewswire

5 hours ago

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

5 hours ago

MAPS Attends Historic FDA Hearing on Psychedelics

Indeterminate GlobeNewswire

5 hours ago

Ultragenyx Announces Approval of FAYUVI™ Gene Therapy, the First-Ever FDA-Approved Treatment for Sanfilippo Syndrome Type A (MPS IIIA)

Indeterminate GlobeNewswire

5 hours ago

GOA Therapeutics Emerges from Stealth with $15.5 Million in Funding and Unveils GOA26, a First-in-Class Drug Candidate for Acute Alcohol Intoxication and Poisoning

Indeterminate GlobeNewswire

6 hours ago

AVAVA Announces $45 Million Financing Led by Catalio Capital Management to Accelerate Next Phase of Growth

Indeterminate GlobeNewswire

6 hours ago

FDA Approves First Gene Therapy for Pediatric Patients with Sanfilippo Syndrome Type A

Indeterminate GlobeNewswire

7 hours ago

Ultrahuman Launches HealthEx PowerPlug to Combine Medical Records with Continuous Ultrahuman Ring Data for Always-on Health Awareness

Indeterminate GlobeNewswire

8 hours ago

uMETHOD Health Publishes Peer-Reviewed Study Documenting Favorable Cognitive Outcomes for its AI-generated RestoreU Care Plans

Indeterminate GlobeNewswire

9 hours ago

PracticeLink Opens Fall 2026 First Practice Fund Applications

Indeterminate GlobeNewswire

10 hours ago

FemPulse Ring Gains CE Mark Certification for the EU

Indeterminate GlobeNewswire